wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q51756510-85308E89-7F64-45F6-B02A-BA9F6DBB2CAC
Q51756510-85308E89-7F64-45F6-B02A-BA9F6DBB2CAC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51756510-85308E89-7F64-45F6-B02A-BA9F6DBB2CAC
Severe, refractory, non-malignant type I cryoglobulinemia treated with alemtuzumab.
P2860
Q51756510-85308E89-7F64-45F6-B02A-BA9F6DBB2CAC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51756510-85308E89-7F64-45F6-B02A-BA9F6DBB2CAC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
34c3390ecebb84626f5846d702b7cc366dbe7981
P2860
Alemtuzumab induces enhanced apoptosis in vitro in B-cells from patients with chronic lymphocytic leukemia by antibody-dependent cellular cytotoxicity.